N
Nikolaus Deigendesch
Researcher at Max Planck Society
Publications - 9
Citations - 4234
Nikolaus Deigendesch is an academic researcher from Max Planck Society. The author has contributed to research in topics: Innate immune system & Superoxide dismutase. The author has an hindex of 6, co-authored 7 publications receiving 3000 citations.
Papers
More filters
Journal ArticleDOI
Neuroinflammation in Alzheimer's disease
Michael T. Heneka,Monica J. Carson,Joseph El Khoury,Gary E. Landreth,Frederic Brosseron,Douglas L. Feinstein,Andreas H. Jacobs,Tony Wyss-Coray,Tony Wyss-Coray,Javier Vitorica,Richard M. Ransohoff,Karl Herrup,Sally A. Frautschy,Bente Finsen,Guy C. Brown,Alexei Verkhratsky,Alexei Verkhratsky,Alexei Verkhratsky,Koji Yamanaka,Jari Koistinaho,Eicke Latz,Eicke Latz,Annett Halle,Gabor C. Petzold,Terrence Town,Dave Morgan,Mari L. Shinohara,V. Hugh Perry,Clive Holmes,Clive Holmes,Nicolas G. Bazan,David J. Brooks,Stéphane Hunot,Bertrand Joseph,Nikolaus Deigendesch,Olga Garaschuk,Erik Boddeke,Charles A. Dinarello,John C.S. Breitner,Greg M. Cole,Douglas T. Golenbock,Markus P. Kummer +41 more
TL;DR: Genome-wide analysis suggests that several genes that increase the risk for sporadic Alzheimer's disease encode factors that regulate glial clearance of misfolded proteins and the inflammatory reaction.
Journal ArticleDOI
Cell-Cycle Proteins Control Production of Neutrophil Extracellular Traps.
Borko Amulic,Sebastian Lorenz Knackstedt,Ulrike Abu Abed,Nikolaus Deigendesch,Christopher J. Harbort,Brian E. Caffrey,Volker Brinkmann,Frank L. Heppner,Philip W. Hinds,Arturo Zychlinsky +9 more
TL;DR: It is shown that NETs are induced by mitogens and accompanied by induction of cell-cycle markers, including phosphorylation of the retinoblastoma protein and lamins, nuclear envelope breakdown, and duplication of centrosomes, and that the response is inhibited by the cell- cycle inhibitor p21Cip.
Journal ArticleDOI
Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage.
Anannya Bhattacharya,Ahmed N. Hegazy,Nikolaus Deigendesch,Lindsay Kosack,Jovana Cupovic,Richard Kumaran Kandasamy,Andrea Hildebrandt,Doron Merkler,Anja A. Kühl,Bojan Vilagos,Christopher Schliehe,Isabel Panse,Isabel Panse,Kseniya Khamina,Hatoon Baazim,Isabelle C. Arnold,Lukas Flatz,Haifeng C. Xu,Philipp A. Lang,Alan Aderem,Akinori Takaoka,Giulio Superti-Furga,Jacques Colinge,Burkhard Ludewig,Max Löhning,Max Löhning,Andreas Bergthaler +26 more
TL;DR: The results delineate IFN-I mediated oxidative stress as a key mediator of virus-induced liver damage and describe a mechanism of innate-immunity-driven pathology, linking IFn-I signaling with antioxidant host defense and infection-associated tissue damage.
Journal ArticleDOI
Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
André Maier,Nikolaus Deigendesch,Kathrin Muller,Jochen H. Weishaupt,Alexander Krannich,Robert Röhle,Felix Meissner,Kaaweh Molawi,Christoph Münch,Teresa Holm,Robert Meyer,Thomas Meyer,Arturo Zychlinsky +12 more
TL;DR: This study showed that blocking IL–1 is safe in patients with ALS, and further trials should test whether targeting IL-1 more efficiently can help treating this devastating disease.
Journal ArticleDOI
Copper Regulates the Canonical NLRP3 Inflammasome.
TL;DR: It is demonstrated that NLRP3 inflammasome activation is blocked by removing copper from the active site of superoxide dismutase 1, recapitulating impaired inflammaome function insuperoxide dismUTase 1–deficient mice, indicating that targeting the intracellular copper homeostasis has potential for the treatment ofNLRP3-dependent diseases.